IBUPROFEN
- Product NDC
- 41226-601
- 11-digit product format
- 412260601
- Labeler code
- 41226
- Product ID
- 41226-601_3f89772f-94d8-4e14-e063-6294a90a769b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- IBUPROFEN
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Kroger Company
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-04-10
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IBUPROFEN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310965 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bbedfc37-913d-8046-e053-2995a90af68a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41226-601-01 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-01 | IBUPROFEN | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 41226-601-05 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-05 | IBUPROFEN | 50 in 1 BOTTLE | TABLET, COATED | 50 | 6 | |
| 41226-601-10 | IBUPROFEN | 2 in 1 PACKAGE, COMBINATION | TABLET, COATED | 2 | 6 | |
| 41226-601-20 | IBUPROFEN | 200 in 1 BOTTLE | TABLET, COATED | 200 | 6 | |
| 41226-601-25 | IBUPROFEN | 250 in 1 BOTTLE | TABLET, COATED | 250 | 6 | |
| 41226-601-42 | IBUPROFEN | 24 in 1 BOTTLE | TABLET, COATED | 24 | 6 | |
| 41226-601-42 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-53 | IBUPROFEN | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PANADOL Extra | ACETAMINOPHEN AND CAFFEINE | Haleon US Holdings LLC | e5c2d88a-d903-4ca0-b895-f27e791dfc4e | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | 9d384e88-5c11-4600-ac6c-a38371570138 | 2024-02-06 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | 95801755-db54-4ad7-bec1-52671914f6ca | 2024-02-06 | Warnings | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 01e7dddb-755c-4745-b701-edcdb6209064 | 2024-02-06 | Warnings, Adverse reactions | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | fe7cd1f2-9b00-4ded-99c2-8a152c71093c | 2024-02-06 | Warnings, Adverse reactions | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 9064943f-836f-4853-b6f2-2c4879941eeb | 2024-02-02 | Warnings | M013 |
| Quality Choice Effervescent Pain Relief | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 079af5d7-1be8-2a93-e063-6294a90a496d | 2024-02-01 | Warnings | M013 |
| MEDI-FIRST Non-Aspirin | ACETAMINOPHEN | Proficient Rx LP | 4c84948d-3a95-4c53-8529-7e7b9d8bb6df | 2024-02-01 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN | Proficient Rx LP | 9c7d65e4-df2f-47c1-a185-66aaf19aad2b | 2024-02-01 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | Proficient Rx LP | 57e4820c-b4eb-442e-9c49-93eedfbc5e5e | 2024-02-01 | Warnings | M013 |
| good sense aspirin | ASPIRIN | Proficient Rx LP | 73013074-9c6e-43c7-acde-4d9d8ed0133d | 2024-02-01 | Warnings | M013 |
| MEDIQUE APAP Extra Strength | ACETAMINOPHEN | Proficient Rx LP | c466a07f-2339-4cf5-8377-e0f109649c52 | 2024-02-01 | Warnings | M013 |
| Percogesic Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE | Medtech Products Inc. | 2c5f1140-fb83-42c9-b0b1-5e2bd69340bb | 2024-02-01 | Warnings | M013 |
| aspirin | ASPIRIN | Proficient Rx LP | 3c7783a7-2b28-4968-b766-0a49dc70ce6d | 2024-02-01 | Warnings | M013 |
| Regular Strength Pain Relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 102bdcde-cb90-f248-e063-6394a90aac79 | 2024-01-30 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | 61802b27-c9ec-4386-9d44-45e8b1e558b7 | 2024-01-28 | Warnings | M013 |
| AGRIFEN | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | 0fde22da-cdfc-36cc-e063-6294a90a3885 | 2024-01-26 | Warnings | M013 |
| DOLODOL | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e80536f1-92cc-5bb3-e053-2995a90a9540 | 2024-01-26 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | Bryant Ranch Prepack | d913d11f-c7a1-49d2-a2d3-9a29fc032806 | 2024-01-18 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310965 | ibuprofen 200 MG Oral Tablet | PSN | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
| 310965 | ibuprofen 200 MG Oral Tablet | SCD | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
| 310965 | ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet | SY | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41226-601-01 | 41226060101 | 1 BOTTLE in 1 CARTON (41226-601-01) / 100 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-06-12 | 0000-00-00 | No | No | Current |
| 41226-601-05 | 41226060105 | 1 BOTTLE in 1 CARTON (41226-601-05) / 50 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-06-12 | 0000-00-00 | No | No | Current |
| 41226-601-10 | 41226060110 | 2 BOTTLE in 1 PACKAGE, COMBINATION (41226-601-10) / 500 TABLET, COATED in 1 BOTTLE (41226-601-53) | 2 bottle | 2024-04-15 | No | No | Current | |
| 41226-601-20 | 41226060120 | 200 TABLET, COATED in 1 BOTTLE (41226-601-20) | 2021-06-12 | 0000-00-00 | No | No | Current | |
| 41226-601-25 | 41226060125 | 250 TABLET, COATED in 1 BOTTLE (41226-601-25) | 2021-06-12 | 0000-00-00 | No | No | Current | |
| 41226-601-42 | 41226060142 | 1 BOTTLE in 1 CARTON (41226-601-42) / 24 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-04-10 | 0000-00-00 | No | No | Current |
| 41226-601-53 | 41226060153 | 500 TABLET, COATED in 1 BOTTLE (41226-601-53) | 2024-04-15 | No | No | Current |